Therapeutic potential of resveratrol in Alzheimer's disease
Open Access
- 3 December 2008
- journal article
- review article
- Published by Springer Nature in BMC Neuroscience
- Vol. 9 (S2) , S6
Abstract
Several epidemiological studies indicate that moderate consumption of red wine is associated with a lower incidence of dementia and Alzheimer's disease. Red wine is enriched in antioxidant polyphenols with potential neuroprotective activities. Despite scepticism concerning the bioavailability of these polyphenols, in vivo data have clearly demonstrated the neuroprotective properties of the naturally occurring polyphenol resveratrol in rodent models for stress and diseases. Furthermore, recent work in cell cultures and animal models has shed light on the molecular mechanisms potentially involved in the beneficial effects of resveratrol intake against the neurodegenerative process in Alzheimer's disease.Keywords
This publication has 56 references indexed in Scilit:
- SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosisThe EMBO Journal, 2007
- Resveratrol stimulates AMP kinase activity in neuronsProceedings of the National Academy of Sciences, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic modelsNeurobiology of Aging, 2005
- Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's diseaseThe FASEB Journal, 2005
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD MutationsCell, 2003
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial CellsHypertension, 2001